Mirena lawsuits' MDL 2767 linked to intracranial hypertension also called pseudotumor cerebri were centralized in April 2017 before Judge Paul A. Engelmayer in the U.S. District Court for the Southern District of New York. This MDL is moving forward speedily. With the first phase of discovery initiated, depositions are taking place proving to be a critical time for the plaintiffs. The defendant, Bayer, continues to maintain that its Mirena is a safe and effective method of birth control. The Daubert Hearings are scheduled to begin early 2018.
